Savaria Co. (TSE:SIS) Receives Average Rating of "Buy" from Analysts

Key Points

• Analysts remain bullish on Savaria: All nine analysts covering the stock recommend buying it, including one “strong buy” rating. The average 12-month price target is C$34.33, with recent targets ranging from C$37.00 to C$39.00.
• Savaria reported quarterly EPS of C$0.35 on revenue of C$245.78 million, alongside a 13.41% return on equity and a 9.27% net margin.
• The stock opened at C$28.66 and has traded between C$20.10 and C$31.95 over the past year. Insiders have sold 81,747 shares worth approximately C$2.45 million in the last 90 days, while insiders retain a 17.45% ownership stake.

Shares of Savaria Co. (TSE:SIS - Get Free Report) have been assigned an average recommendation of "Buy" from the nine analysts that are covering the stock, MarketBeat.com reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is C$34.33.

Several brokerages have recently issued reports on SIS. TD Securities upgraded Savaria to a "strong-buy" rating in a report on Friday, July 24th. TD increased their price objective on Savaria from C$35.00 to C$37.00 and gave the stock a "buy" rating in a report on Friday, August 7th. ATB Cormark Capital Markets raised their price objective on shares of Savaria from C$35.00 to C$38.00 and gave the company an "outperform" rating in a research report on Friday, August 7th. Finally, Desjardins lifted their target price on shares of Savaria from C$36.00 to C$39.00 and gave the company a "buy" rating in a research note on Friday, August 7th.

Savaria Price Performance

Shares of TSE:SIS opened at C$28.66 on Monday. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 29.43. Savaria has a 1 year low of C$20.10 and a 1 year high of C$31.95. The business has a fifty day simple moving average of C$29.81 and a 200 day simple moving average of C$28.17. The firm has a market cap of C$2.07 billion, a price-to-earnings ratio of 23.69, a P/E/G ratio of 42.72 and a beta of 1.04.

Savaria (TSE:SIS - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported C$0.35 earnings per share (EPS) for the quarter. Savaria had a return on equity of 13.41% and a net margin of 9.27%.The firm had revenue of C$245.78 million during the quarter. As a group, sell-side analysts predict that Savaria will post 1.2048518 earnings per share for the current fiscal year.

Insider Buying and Selling at Savaria

In related news, Director Les Teague sold 5,000 shares of Savaria stock in a transaction on Friday, June 26th. The shares were sold at an average price of C$28.92, for a total value of C$144,600.00. Also, Director Marcel Bourassa sold 7,500 shares of the company's stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of C$29.53, for a total transaction of C$221,475.00. Following the completion of the sale, the director owned 225,431 shares of the company's stock, valued at C$6,656,977.43. This represents a 3.22% decrease in their ownership of the stock. In the last 90 days, insiders have sold 81,747 shares of company stock worth $2,448,032. Company insiders own 17.45% of the company's stock.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source